CTKB vs XOM · rev $92.3M vs P/E 24, rev $201.16B
Cytek Biosciences Inc (CTKB) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
CTKB currently screens at market cap $421.8M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the CTKB and XOM stock pages for the full models.
Not investment advice.